Int6 expression can predict survival in early-stage non-small cell lung cancer patients

43Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

Purpose: The Int6 gene was originally identified as a common insertion site for the mouse mammary tumor virus in virally induced mouse mammary tumors. Recent studies indicate that Int6 is a multifaceted protein involved in the regulation of protein translation and degradation through binding with three complexes: the eukaryotic translation initiation factor 3, the proteasome regulatory lid, and the constitutive photomorphogenesis 9 signalosome. This study aimed to investigate the prognostic role of Int6 in a large series of stage I non - small cell lung cancers (NSCLC) patients with long-term follow-up. Experimental Design: We determined the methylation status of Int6 DNA by methylation-specific PCR and the steady-state levels of Int6 RNA by quantitative real-time reverse transcription-PCR in 101 NSCLCs and matched normal lung tissues. Results: In 27% of the tumors, Int6 RNA levels were reduced relative to normal tissue. In 85% of the tumors with reduced Int6 expression, the transcription promoter and first exon were hypermethylated, whereas only 4% of the tumors with elevated Int6 RNA levels were hypermethylated (P < 0.000001). Low levels of of Int6 RNA were found a significant predictor of overall and disease-free survival (P = 0.0004 and P = 0.0020, respectively). A multivariate analysis confirmed that low Int6 expression was the only independent factor to predict poor prognosis, for both overall (P = 0.0006) and disease-free (P = 0.024) survival. Conclusions: Our results suggest that Int6 expression evaluated by quantitative real-time PCR, may represent a new prognostic factor in patients with stage I NSCLC. © 2005 American Association for Cancer Research.

Cite

CITATION STYLE

APA

Buttitta, F., Martella, C., Barassi, F., Felicioni, L., Salvatore, S., Rosini, S., … Marchetti, A. (2005). Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clinical Cancer Research, 11(9), 3198–3204. https://doi.org/10.1158/1078-0432.CCR-04-2308

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free